对喘和肺炎风险的生物药物
Maria Gabriella Matera1, Josuel Ora2, Luigino Calzetta3
1Unit of Pharmacology, Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
概括
生物药物如梅波利祖马布,奥马利祖马布和本拉利祖马布可能会增加严重喘患者的肺炎风险. 杜皮卢马布没有显示出这种关联. 需要进一步的现实研究来证实这些发现.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药物监督 药物监督 药物监督
背景情况:
- 严重喘的生物疗法调节免疫系统,提高了理论上的感染风险.
- 在严重喘中,特定生物药物和肺炎发展之间的关联仍然不清楚.
研究的目的:
- 调查奥马利祖马布,梅波利祖马布,本拉利祖马布和杜比卢马布与肺炎风险之间的现实世界联系.
主要方法:
- 来自FAERS的不良事件报告的回顾性分析 (2020年1月至2023年9月).
- 使用MedDRA来识别感染和感染中的肺炎病例.
- 计算报告几率比率 (ROR) 和比例报告比率 (PRR) 来评估不成比例.
主要成果:
- 梅波利祖马布 (36.8%),奥马利祖马布 (32.6%) 和本拉利祖马布 (19.2%) 与杜皮卢马布 (5.7%) 相比,肺炎病例的百分比更高.
- 对梅波利祖马布 (ROR=3.74),奥马利祖马布 (ROR=3.26) 和本拉利祖马布 (ROR=2.65) 观察到增加肺炎风险的中度至强信号.
- 杜皮卢马布与肺炎报告的增加无关.
结论:
- 梅波利祖马布,奥马利祖马布和本拉利祖马布与较高的肺炎报告相关,而不是dupilumab.
- 这些发现表明潜在的关联,而不是因果关系,需要通过强大的现实世界研究设计进行进一步调查.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
15:43Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
22.8K
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
300
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
300
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
251
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
251
01:30Pneumonia I: Introduction
239
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239